Singapore markets open in 3 hours 21 minutes

Phathom Pharmaceuticals, Inc. (PHAT)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
9.95+1.76 (+21.49%)
At close: 04:00PM EDT
9.46 -0.49 (-4.92%)
After hours: 04:54PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 312.19M
Enterprise value 220.27M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)4.33
Enterprise value/revenue N/A
Enterprise value/EBITDA -1.56

Trading information

Stock price history

Beta (5Y monthly) 0.99
52-week change 3-75.16%
S&P500 52-week change 3-2.90%
52-week high 339.02
52-week low 36.74
50-day moving average 313.27
200-day moving average 321.65

Share statistics

Avg vol (3-month) 3192.69k
Avg vol (10-day) 3577.2k
Shares outstanding 539.07M
Implied shares outstanding 6N/A
Float 814.05M
% held by insiders 124.29%
% held by institutions 160.00%
Shares short (28 Apr 2022) 42.5M
Short ratio (28 Apr 2022) 422.03
Short % of float (28 Apr 2022) 410.29%
Short % of shares outstanding (28 Apr 2022) 46.41%
Shares short (prior month 30 Mar 2022) 42.07M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Dec 2021

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-34.85%
Return on equity (ttm)-108.01%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -134.56M
Net income avi to common (ttm)-143.88M
Diluted EPS (ttm)-3.89
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)183.26M
Total cash per share (mrq)5.99
Total debt (mrq)91.34M
Total debt/equity (mrq)126.59
Current ratio (mrq)9.86
Book value per share (mrq)2.37

Cash flow statement

Operating cash flow (ttm)-148.62M
Levered free cash flow (ttm)-96.73M